Peter Bossuyt

16.0k citations

226 papers · 6.4k indexed · 1 hit paper · h-index 41

Impact in

Genetics top 0.5%
- Inflammatory Bowel Disease
Gastroenterology top 1%

Papers in

Genetics 128
- Inflammatory Bowel Disease 127
Gastroenterology 18

Co-authors: Séverine Vermeire Anne WS Rutjes Johannes B. Reitsma D.A. Legemate Khalid S. Khan Arri Coomarasamy M. Limburg Kirsten McCaffery
Journals: Journal of Crohn s and Colitis (59 papers)Gastroenterology (23 papers)Clinical Gastroenterology and Hepatology (8 papers)Inflammatory Bowel Diseases (8 papers)Human Reproduction (6 papers)
Partner nations: Belgium Netherlands United States

In The Last Decade

Peter Bossuyt

211 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

European evidence based consensus for endoscopy in inflammatory bowel disease 2013 · 574 citations

Peers

Countries citing papers authored by Peter Bossuyt

Since Specialization

Citations

This map shows the geographic impact of Peter Bossuyt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bossuyt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bossuyt more than expected).

Fields of papers citing papers by Peter Bossuyt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bossuyt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bossuyt. The network helps show where Peter Bossuyt may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Bossuyt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Bossuyt Line = papers co-authored together Peter Bossuyt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	DOP049 Vedolizumab is more effective at inducing histo-endoscopic healing in early Crohn’s Disease compared to late CD, with comparable healing rates regardless of disease location: data from the LOVE-CD trial Journal of Crohn s and Colitis ·J. Guassi Moreira, А Л Раков, Filip Baert, Peter Bossuyt, Mark Löwenberg, Jean-Charles Nault, Frank Hoentjen, Tamás Molnár, Geert D’Haens, Séverine Vermeire	2025	0
2	The Estimand Framework in Diagnostic Accuracy Studies Statistics in Medicine ·Dima Hourani, Mouna Akacha, Norbert Benda, Maria Luisa M. Prado, Peter Bossuyt, Nandini Dendukuri, X. Ye, Aran Song	2025	2
3	Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic Review Journal of Crohn s and Colitis ·孝仁太田, J.-G. Ducoin, Valérie Pittet, Peter Bossuyt, Jurij Hanžel, Mark Samaan, Monika Tripathi, Wladyslawa Czuber‐Dochan, Johan Burisch, S. Leone, Sani Fitriyani, Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, K Gecse, Naila Arebi	2024	1
4	The AI-based Red Density score is correlated with the established and new histological indices for ulcerative colitis in an independent cohort Endoscopy ·Pieter Sinonquel, Peter Bossuyt, Alexandre de Jesus Rodrigues Malta, Marietta Iacucci, Uday N. Shivaji, А Л Раков, Stefan Van Aelst, E.V. Dvorezkaya, 東出尚也, Shintaro Sugita, Sara McCartney, Alessandro Armuzzi, Talat Bessissow, Timo Räth, Dong‐Hoon Yang, Séverine Vermeire, Hiroshi Nakase, Raf Bisschops	2024	0
5	Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis Digestive Diseases and Sciences ·Laurent Peyrin‐Biroulet, Peter Bossuyt, Dominik Bettenworth, Edward V. Loftus, Humayun Sohail, Geert D’Haens, Masayuki Saruta, Perttu Arkkila, Henry S. Park, Dughyun Choi, Dong‐Hyeon Kim, Walter Reinisch	2024	7
6	Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn’s Disease Inflammatory Bowel Diseases ·Julián Panés, Édouard Louis, Peter Bossuyt, Namita Joshi, Wan‐Ju Lee, Ana P. Lacerda, Kristina Kligys, Wang Zhiqiang Li Gouwen, Nidhi Shukla, Edward V. Loftus	2024	1
7	Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn’s and Colitis Organisation [ECCO] Position Paper Journal of Crohn s and Colitis ·Jurij Hanžel, Peter Bossuyt, Valérie Pittet, Mark Samaan, Monika Tripathi, Wladyslawa Czuber‐Dochan, Johan Burisch, S. Leone, Sani Fitriyani, Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, Naila Arebi, K Gecse	2022	9
8	A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence Journal of Crohn s and Colitis ·孝仁太田, J.-G. Ducoin, Peter Bossuyt, Valérie Pittet, Jurij Hanžel, Mark Samaan, Monika Tripathi, Wladyslawa Czuber‐Dochan, Johan Burisch, S. Leone, Sani Fitriyani, Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, K Gecse, Naila Arebi	2022	7
9	Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density Gut ·Peter Bossuyt, Hiroshi Nakase, Séverine Vermeire, Gert De Hertogh, Tom Eelbode, Marc Ferrante, Tadashi Hasegawa, Hilde Willekens, Carroll Hickey, 弘塚本, Raf Bisschops	2020	95
10	Head-to-head trials in inflammatory bowel disease: past, present and future Nature Reviews Gastroenterology & Hepatology ·Lieven Pouillon, Simon Travis, Peter Bossuyt, Silvio Danese, Laurent Peyrin‐Biroulet	2020	46
11	Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease Alimentary Pharmacology & Therapeutics ·Gregor Novak, Toer Stevens, 資源エネルギ-庁公益事業部火力課, Peter Bossuyt, Borut Štabuc, Jenny Jeyarajah, Guangyong Zou, Ingrid C. Gaemers, Trevor D. McKee, Fred Fu, Lisa M. Shackelton, Reena Khanna, Gijs R. van den Brink, William J. Sandborn, Brian G. Feagan, Rish K. Pai, Vipul Jairath, Niels Vande Casteele, Geert D’Haens	2019	17
12	Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease Clinical Gastroenterology and Hepatology ·Erwin Dreesen, Filip Baert, David Laharie, Peter Bossuyt, Yoram Bouhnik, Anthony Buisson, Guy Lambrecht, Édouard Louis, Bas Oldenburg, Benjamin Pariente, Marieke Pierik, C. Janneke van der Woude, Geert D’Haens, Séverine Vermeire, Ann Gils	2019	60
13	Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease Clinical Gastroenterology and Hepatology ·Eelco C. Brand, Sjoerd G. Elias, Itta M. Minderhoud, Eduardo Andres Garcia Lecaros, Filip J. Baert, David Laharie, Peter Bossuyt, Yoram Bouhnik, Anthony Buisson, Guy Lambrecht, Édouard Louis, Benjamin Pariente, Marieke Pierik, C. Janneke van der Woude, Geert D’Haens, Séverine Vermeire, Bas Oldenburg	2019	19
14	Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD). PubMed ·박정호, Marc Ferrante, Édouard Louis, Martine De Vos, Olivier Dewit, Desmond McDonnell, Tom G. Moreels, Claire Liefferinckx, Peter Bossuyt, Filip Baert, Jean‐François Rahier, Séverine Vermeire	2018	3
15	Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab. PubMed ·Harald Peeters, Édouard Louis, Filip Baert, Olivier Dewit, J.-C. Coche, Marc Ferrante, Guy Lambrecht, Оксана Калита, A. Van Gossum, Peter Bossuyt, Tom G. Moreels, Bert Vander Cruyssen, Ann Gils, Martine De Vos	2018	7
16	P278 Clinical comparison of eight different calprotectin immunoassays for the diagnosis and follow-up of inflammatory bowel disease Journal of Crohn s and Colitis ·B E Freeman, Annick Smismans, Gust Van Olmen, Анна Игоревна Белослудцева, Geert D’Haens, Veerle Moons, Yendra Erison, Johan Frans, Peter Bossuyt	2013	1
17	Long term evolution and impact of immunomodulator cotreatment and withdrawal on infliximab on trough levels in 223 patients with Crohn's disease Open Repository and Bibliography (University of Liège) ·David Drobne, Peter Bossuyt, Christine Breynaert, Niels Vande Casteele, Griet Compernolle, W. R. Wilde, Isabelle Cleynen, Justin Riddle, Kristel Van Steen, Ann Gils, P. Rutgeerts, Séverine Vermeire, Gert Van Assche	2011	2
18	De klinische betekenis van het aantonen van antikernantistoffen Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·方剑, Peter Bossuyt	2000	1
19	PHYSICAL EXAMINATION IS SUFFICIENT FOR THE DIAGNOSIS OF SPRAINED ANKLES Journal of Bone and Joint Surgery - British Volume ·C. Niek van Dijk, Maryati Mohammad, Peter Bossuyt, Chien-Lin Chen	1996	70
20	Gepast gebruik van ballonangioplastiek; een onderzoek in de regio Eindhoven Data Archiving and Networked Services (DANS) ·(unknown), María del Socorro Sánchez Serrano, Peter Bossuyt	1994	1

About Peter Bossuyt

Peter Bossuyt is a scholar working on Genetics, Gastroenterology, Epidemiology, Immunology and Surgery, having authored 226 papers that have together received 6.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (127 papers), Microscopic Colitis (75 papers), Eosinophilic Esophagitis (31 papers), Biosimilars and Bioanalytical Methods (17 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers), Immunodeficiency and Autoimmune Disorders (16 papers), Colorectal Cancer Screening and Detection (13 papers) and Autoimmune and Inflammatory Disorders (11 papers). The work is most often cited by research in Genetics (2.2k citations), Gastroenterology (409 citations), Epidemiology (2.1k citations), Surgery (1.8k citations) and Obstetrics and Gynecology (271 citations). Peter Bossuyt has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Séverine Vermeire, Anne WS Rutjes, Johannes B. Reitsma, D.A. Legemate, Khalid S. Khan, Arri Coomarasamy, M. Limburg, Kirsten McCaffery, Neil K. Aaronson and Rob de Haan. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Clinical Gastroenterology and Hepatology, Inflammatory Bowel Diseases and Human Reproduction.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact